SANTA CLARA, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of ...
Shockwave Medical, Inc. SWAV recently announced the full U.S. commercial availability of the Shockwave L6 Peripheral Intravascular Lithotripsy (IVL) Catheter. This follows the receipt of the FDA’s ...
A detailed agenda for all Shockwave Medical symposia and featured presentations can be found here. While under clinical investigation in the COSIRA-II trial (U.S. and Canada), the Reducer is CE-marked ...
FastWave Medical used 2025 to make uncommon progress for an early-stage company, advancing not one but two differentiated IVL ...
Physicians have a number of tools to treat coronary artery disease, the most common type of heart disease in the United States. But one breakthrough technology being offered at Catholic Medical Center ...
Johnson & Johnson has announced the European launch of its Shockwave Javelin Peripheral IVL Catheter, an intravascular lithotripsy (IVL) platform aimed at addressing calcium buildup in severely ...
SANTA CLARA, Calif., May 15, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of ...
On September 15, 2025, Johnson & Johnson (NYSE:JNJ) announced the European launch of its Shockwave Javelin Peripheral IVL Catheter, which is a groundbreaking platform to treat peripheral artery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback